| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| R&D Expense | $21.3M | -21.7% |
| SG&A Expense | $5.9M | -3.5% |
| Operating Income | -$27.2M | +18.4% |
| Pre-tax Income | $26.6M | +438.5% |
| Net Income | -$26.3M | -449.1% |
| EPS (Basic) | -$62.19 | — |
| EPS (Diluted) | -$62.19 | — |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.5M | +1117.3% |
| Short-term Investments | $7.4M | — |
| Current Assets | $19.9M | +445.4% |
| Total Assets | $21.6M | +268.7% |
| Current Liabilities | $4.0M | -46.7% |
| Stockholders' Equity | $17.3M | +745.6% |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.2M | -16.8% |
| Capital Expenditures | $457K | +0.0% |
| Investing Cash Flow | -$7.6M | -1021.4% |
| Financing Cash Flow | $45.4M | +928.5% |
| Free Cash Flow | -$28.6M | -16.5% |